10th July 2021
Successful therapy of experimental, orthotopic renal cell carcinoma with two different types of AXL-inhibiting agents
Selective AXL inhibitors
10th July 2021
Successful therapy of experimental, orthotopic renal cell carcinoma with two different types of AXL-inhibiting agents
Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.